Heart arrhythmia

Introduction

Heart arrhythmias are disorders of the normal electrical activity of the heart, resulting in irregular heartbeats that may be too fast, too slow, or erratic. They can range from benign conditions to life-threatening events, affecting cardiac output and overall health. Understanding their types, causes, and management is essential for effective patient care.

Definition and Classification

Definition of Heart Arrhythmia

Heart arrhythmia is defined as any deviation from the normal sinus rhythm of the heart, characterized by abnormal rate, rhythm, or conduction. It may be transient or persistent, and its clinical significance varies depending on the type and underlying cause.

Classification Based on Heart Rate

• Tachyarrhythmias: Arrhythmias with a heart rate exceeding 100 beats per minute.
• Bradyarrhythmias: Arrhythmias with a heart rate below 60 beats per minute.

Classification Based on Origin

• Atrial: Arrhythmias originating in the atria, including atrial fibrillation and atrial flutter.
• Ventricular: Arrhythmias originating in the ventricles, such as ventricular tachycardia and ventricular fibrillation.
• Junctional: Arrhythmias arising from the atrioventricular node or junctional tissue.

Paroxysmal, Persistent, and Permanent Arrhythmias

• Paroxysmal: Arrhythmias that occur intermittently and terminate spontaneously.
• Persistent: Arrhythmias that require intervention to restore normal rhythm.
• Permanent: Arrhythmias that persist despite treatment and may require long-term management.

Epidemiology

• Global prevalence and incidence: Heart arrhythmias are common worldwide, with atrial fibrillation being the most prevalent sustained arrhythmia. Incidence increases with age and comorbid conditions.
• Age and sex distribution: The prevalence rises significantly in individuals over 65 years. Men have a slightly higher risk for certain arrhythmias, while women may have different clinical manifestations.
• Risk factors and comorbidities: Hypertension, coronary artery disease, heart failure, diabetes, and obesity increase the risk of developing arrhythmias. Lifestyle factors such as alcohol consumption and smoking also contribute.

Etiology and Pathophysiology

• Structural heart disease: Conditions such as myocardial infarction, cardiomyopathy, and valvular disease can alter cardiac conduction pathways.
• Electrophysiological abnormalities: Abnormal automaticity, triggered activity, and re-entry circuits can lead to arrhythmogenesis.
• Genetic predisposition: Inherited channelopathies like long QT syndrome and Brugada syndrome increase susceptibility to arrhythmias.
• Metabolic and electrolyte disturbances: Abnormal levels of potassium, calcium, and magnesium can disrupt electrical conduction.
• Medication-induced arrhythmias: Certain drugs, including antiarrhythmics, antidepressants, and antibiotics, may provoke arrhythmias.
• Autonomic nervous system influences: Imbalance between sympathetic and parasympathetic activity can trigger or exacerbate arrhythmias.

Clinical Features

Symptoms

• Palpitations: Sensation of rapid, irregular, or forceful heartbeats.
• Dizziness and syncope: Lightheadedness or fainting episodes due to transient cerebral hypoperfusion.
• Shortness of breath: Dyspnea during exertion or at rest, often due to impaired cardiac output.
• Chest discomfort: Pressure or pain in the chest, sometimes associated with myocardial ischemia.

Signs

• Irregular pulse: Varies in rate, rhythm, and strength depending on arrhythmia type.
• Bradycardia or tachycardia on examination: Heart rate may be abnormally slow or fast.
• Hypotension or signs of heart failure: Peripheral edema, jugular venous distension, or pulmonary congestion may occur in severe cases.

Types of Arrhythmias

Atrial Arrhythmias

• Atrial fibrillation: Rapid, irregular atrial activity causing irregular ventricular response.
• Atrial flutter: Rapid, regular atrial contractions, often leading to fast ventricular rates.
• Supraventricular tachycardia (SVT): Abrupt onset and termination of rapid heart rate originating above the ventricles.

Ventricular Arrhythmias

• Ventricular tachycardia: Rapid heart rate originating from the ventricles, may be sustained or nonsustained.
• Ventricular fibrillation: Chaotic ventricular activity leading to loss of cardiac output and sudden cardiac arrest.
• Premature ventricular contractions (PVCs): Early ventricular beats causing palpitations, often benign but may indicate underlying heart disease.

Bradyarrhythmias

• Sinus bradycardia: Slow heart rate due to reduced sinus node automaticity.
• Heart block: Impaired conduction through the atrioventricular node, classified as first, second, or third degree.
• Junctional rhythms: Heartbeats originating from the AV junction, often causing slow or irregular rhythm.

Diagnostic Evaluation

• Electrocardiography (ECG): The primary tool for detecting and characterizing arrhythmias, providing information on rhythm, conduction intervals, and underlying cardiac conditions.
• Holter monitoring and event recorders: Continuous or intermittent ECG recording over 24 hours to several weeks to capture transient or paroxysmal arrhythmias.
• Electrophysiological studies: Invasive testing to map electrical pathways, identify arrhythmogenic foci, and guide ablation therapy.
• Imaging studies: Echocardiography assesses structural heart disease, while cardiac MRI can identify myocardial scarring or fibrosis contributing to arrhythmias.
• Laboratory tests: Electrolyte panels, thyroid function tests, and cardiac biomarkers help identify reversible causes or complications of arrhythmias.

Management and Treatment

Pharmacological Therapy

• Antiarrhythmic drugs: Medications such as amiodarone, flecainide, or sotalol are used to restore or maintain normal rhythm.
• Rate control medications: Beta-blockers, calcium channel blockers, and digoxin are used to control ventricular rate in atrial arrhythmias.
• Anticoagulation: Indicated in patients with atrial fibrillation or flutter to reduce the risk of thromboembolism and stroke.

Non-Pharmacological Therapy

• Cardioversion: Electrical or pharmacological procedures to restore normal sinus rhythm in selected arrhythmias.
• Catheter ablation: Invasive procedure to eliminate arrhythmogenic tissue responsible for recurrent arrhythmias.
• Pacing and implantable cardioverter-defibrillators (ICDs): Devices used for bradyarrhythmias, high-risk ventricular arrhythmias, or prevention of sudden cardiac death.

Lifestyle and Risk Factor Modification

• Management of comorbidities: Control of hypertension, diabetes, coronary artery disease, and heart failure to reduce arrhythmia risk.
• Diet, exercise, and avoidance of arrhythmogenic substances: Limiting alcohol, caffeine, and stimulant medications, along with regular physical activity, helps maintain cardiac rhythm stability.

Prognosis and Complications

• Risk of stroke and thromboembolism: Particularly in atrial fibrillation, stagnant blood flow in the atria can lead to clot formation and embolic events.
• Heart failure and cardiomyopathy: Persistent arrhythmias may impair ventricular function, causing heart failure or tachycardia-induced cardiomyopathy.
• Sudden cardiac death: Ventricular arrhythmias such as ventricular fibrillation are major causes of sudden cardiac death.
• Long-term quality of life: Recurrent arrhythmias can lead to fatigue, exercise intolerance, anxiety, and decreased daily functioning.

References

1. Zipes DP, Jalife J. Cardiac Electrophysiology: From Cell to Bedside. 7th ed. Philadelphia: Elsevier; 2018.
2. Otto CM. Textbook of Clinical Echocardiography. 6th ed. Philadelphia: Elsevier; 2018.
3. Josephson ME. Clinical Cardiac Electrophysiology: Techniques and Interpretations. 5th ed. Philadelphia: Wolters Kluwer; 2015.
4. Kannel WB, Benjamin EJ. Current perspectives on atrial fibrillation: the Framingham Study. Clin Cardiol. 2009;32(5):3-7.
5. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012;33(21):2719-2747.
6. Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/HRS guideline for the management of atrial fibrillation. J Am Coll Cardiol. 2011;57(11):e101-e198.
7. Steinberg JS, Zipes DP. Clinical Arrhythmology and Electrophysiology: A Companion to Braunwald’s Heart Disease. 3rd ed. Philadelphia: Elsevier; 2017.
8. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update on atrial fibrillation. Circulation. 2019;140(2):e125-e151.
9. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for management of patients with supraventricular arrhythmias. Eur Heart J. 2003;24(20):1857-1897.
10. Steinberg JS. Ventricular Arrhythmias. N Engl J Med. 2016;375:1962-1971.